BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22744722)

  • 1. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.
    Lin SY; Lu PL; Tsai KB; Lin CY; Lin WR; Chen TC; Chang YT; Huang CH; Chen CY; Lai CC; Chen YH
    Mycopathologia; 2012 Dec; 174(5-6):499-504. PubMed ID: 22744722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Gholinejad Ghadi N; Seifi Z; Shokohi T; Aghili SR; Nikkhah M; Vahedi Larijani L; Ghasemi M; Haghani I
    J Mycol Med; 2018 Jun; 28(2):399-402. PubMed ID: 29545122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
    Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
    Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole.
    Reich P; Shute T; Lysen C; Lockhart SR; Kelly Keating M; Custer P; Orscheln R
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e169-e171. PubMed ID: 29522137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis.
    Manesh A; John AO; Mathew B; Varghese L; Rupa V; Zachariah A; Varghese GM
    Mycoses; 2016 Dec; 59(12):765-772. PubMed ID: 27443253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Part 2: mucormycosis: focus on therapy.
    Lynch JP; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhino-orbito-cerebral mucormycosis: five cases.
    Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
    Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy.
    Almannai M; Imran H; Estrada B; Siddiqui AH
    Pediatr Hematol Oncol; 2013 Apr; 30(3):184-6. PubMed ID: 23444832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucormycosis treated with posaconazole: review of 96 case reports.
    Vehreschild JJ; Birtel A; Vehreschild MJ; Liss B; Farowski F; Kochanek M; Sieniawski M; Steinbach A; Wahlers K; Fätkenheuer G; Cornely OA
    Crit Rev Microbiol; 2013 Aug; 39(3):310-24. PubMed ID: 22917084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Unusual Case of Pulmonary Mucormycosis.
    Thomas S; Pawar B; Fernandes D; Nayar S; George P; Cherian S
    Transplant Proc; 2018 Dec; 50(10):3943-3945. PubMed ID: 30503525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis in renal transplant recipients: review of 174 reported cases.
    Song Y; Qiao J; Giovanni G; Liu G; Yang H; Wu J; Chen J
    BMC Infect Dis; 2017 Apr; 17(1):283. PubMed ID: 28420334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Treatment of
    Parize P; Mamez AC; Garcia-Hermoso D; Dumaine V; Poirée S; Kauffmann-Lacroix C; Jullien V; Lortholary O; Lanternier F
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucormycosis.
    Steinbrink JM; Miceli MH
    Infect Dis Clin North Am; 2021 Jun; 35(2):435-452. PubMed ID: 34016285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole.
    Yuan F; Chen J; Liu F; Dang YC; Kong QT; Sang H
    Eur J Med Res; 2021 Nov; 26(1):131. PubMed ID: 34775981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
    Jantunen E; Kolho E; Ruutu P; Koukila-Kähkölä P; Virolainen M; Juvonen E; Volin L
    Bone Marrow Transplant; 1996 Jul; 18(1):229-30. PubMed ID: 8832023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
    Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
    Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans.
    Reddy IS; Rao NR; Shankar Reddy VM; Rao R
    Indian J Dermatol Venereol Leprol; 2008; 74(4):367-70. PubMed ID: 18797060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhino-orbital mucormycosis due to Apophysomyces ossiformis in a patient with diabetes mellitus: a case report.
    Martínez-Herrera E; Frías-De-León MG; Julián-Castrejón A; Cruz-Benítez L; Xicohtencatl-Cortes J; Hernández-Castro R
    BMC Infect Dis; 2020 Aug; 20(1):614. PubMed ID: 32811466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.